Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Glifozines and cardio-renal outcomes.

Di Lullo L, Bellasi A, Guastamacchia E, Triggiani V, Ronco C, Lavalle C, Di Iorio BR, Russo D, Cianciolo G, La Manna G, Settembrini S.

Minerva Cardioangiol. 2020 Feb 20. doi: 10.23736/S0026-4725.20.05078-1. [Epub ahead of print]

PMID:
32083429
2.

Therapeutic management of HIV-infected patients with chronic kidney disease.

Alfano G, Guaraldi G, Fontana F, Bellasi A, Cappelli G.

J Nephrol. 2020 Feb 4. doi: 10.1007/s40620-020-00701-8. [Epub ahead of print] Review.

PMID:
32020538
3.

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.

Bellasi A, Cozzolino M, Malberti F, Cancarini G, Esposito C, Guastoni CM, Ondei P, Pontoriero G, Teatini U, Vezzoli G, Pasquali M, Messa P, Locatelli F.

J Nephrol. 2019 Dec 18. doi: 10.1007/s40620-019-00677-0. [Epub ahead of print]

PMID:
31853791
4.

Associations between echocardiographic findings and prospective changes in residual renal function in patients new to peritoneal dialysis.

Mahdavi S, Yared K, Wu G, Omar B, Savundra D, Nagai G, Hockmann E, Svendrovski A, Bellasi A, Tam P, Sikaneta T.

Sci Rep. 2019 Dec 5;9(1):18434. doi: 10.1038/s41598-019-54851-2.

5.

Mineral and Electrolyte Disorders With SGLT2i Therapy.

Cianciolo G, De Pascalis A, Capelli I, Gasperoni L, Di Lullo L, Bellasi A, La Manna G.

JBMR Plus. 2019 Nov 4;3(11):e10242. doi: 10.1002/jbm4.10242. eCollection 2019 Nov. Review.

6.

Chronic Kidney Disease: The Silent Epidemy.

Bellasi A, Di Lullo L, Di Iorio B.

J Clin Med. 2019 Oct 26;8(11). pii: E1795. doi: 10.3390/jcm8111795.

7.

Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.

Raggi P, Bellasi A, Bushinsky D, Bover J, Rodriguez M, Ketteler M, Sinha S, Salcedo C, Gillotti K, Padgett C, Garg R, Gold A, Perelló J, Chertow GM.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044195. [Epub ahead of print]

PMID:
31707860
8.

Associations of Calcium from Food Sources Versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis Patients.

Mahdavi S, Bellasi A, Nagra K, Johnston L, Tam P, Di Iorio B, Sikaneta T.

J Clin Med. 2019 Oct 14;8(10). pii: E1680. doi: 10.3390/jcm8101680.

9.

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.

Di Iorio BR, Bellasi A, Raphael KL, Santoro D, Aucella F, Garofano L, Ceccarelli M, Di Lullo L, Capolongo G, Di Iorio M, Guastaferro P, Capasso G; UBI Study Group.

J Nephrol. 2019 Dec;32(6):989-1001. doi: 10.1007/s40620-019-00656-5. Epub 2019 Oct 9.

10.

Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient.

Massimetti C, Bellasi A, Modoni A, Gomes V, Feriozzi S.

G Ital Nefrol. 2019 Sep 24;36(5). pii: 2019-vol5.

11.

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study).

Di Iorio BR, Rocchetti MT, De Angelis M, Cosola C, Marzocco S, Di Micco L, di Bari I, Accetturo M, Vacca M, Gobbetti M, Di Iorio M, Bellasi A, Gesualdo L.

J Clin Med. 2019 Sep 10;8(9). pii: E1424. doi: 10.3390/jcm8091424.

12.

Implication of Acute Kidney Injury in Heart Failure.

Ronco C, Bellasi A, Di Lullo L.

Heart Fail Clin. 2019 Oct;15(4):463-476. doi: 10.1016/j.hfc.2019.05.002. Epub 2019 Jul 5. Review.

PMID:
31472882
13.

Kidney Disease in HIV Infection.

Alfano G, Cappelli G, Fontana F, Di Lullo L, Di Iorio B, Bellasi A, Guaraldi G.

J Clin Med. 2019 Aug 19;8(8). pii: E1254. doi: 10.3390/jcm8081254. Review.

14.

Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5.

Bellasi A, Di Micco L, Russo D, De Simone E, Di Iorio M, Vigilante R, Di Lullo L, Di Iorio BR.

J Clin Med. 2019 Jul 12;8(7). pii: E1026. doi: 10.3390/jcm8071026.

15.

Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights.

Di Micco L, Di Lullo L, Bellasi A, Di Iorio BR.

J Clin Med. 2019 May 20;8(5). pii: E718. doi: 10.3390/jcm8050718. Review.

16.

Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.

Ruggiero B, Trillini M, Tartaglione L, Rotondi S, Perticucci E, Tripepi R, Aparicio C, Lecchi V, Perna A, Peraro F, Villa D, Ferrari S, Cannata A, Mazzaferro S, Mallamaci F, Zoccali C, Bellasi A, Cozzolino M, Remuzzi G, Ruggenenti P, Kohan DE; ANSWER Study Organization.

Am J Kidney Dis. 2019 Sep;74(3):338-350. doi: 10.1053/j.ajkd.2019.01.029. Epub 2019 Apr 23.

PMID:
31027883
17.

Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus.

Fusaro M, Gallieni M, Aghi A, Rizzo MA, Iervasi G, Nickolas TL, Fabris F, Mereu MC, Giannini S, Sella S, Giusti A, Pitino A, D'Arrigo G, Rossini M, Gatti D, Ravera M, Di Lullo L, Bellasi A, Brunori G, Piccoli A, Tripepi G, Plebani M.

J Nephrol. 2019 Aug;32(4):635-643. doi: 10.1007/s40620-019-00595-1. Epub 2019 Feb 13.

18.

Search for a reliable biomarker of acute kidney injury: to the heart of the problem.

Di Lullo L, Di Iorio BR, Ronco C, Bellasi A.

Ann Transl Med. 2018 Nov;6(Suppl 1):S5. doi: 10.21037/atm.2018.08.23. No abstract available.

19.

Cardiorenal Syndrome in Acute Kidney Injury.

Di Lullo L, Reeves PB, Bellasi A, Ronco C.

Semin Nephrol. 2019 Jan;39(1):31-40. doi: 10.1016/j.semnephrol.2018.10.003. Review.

PMID:
30606406
20.

Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor.

Di Lullo L, Tripepi G, Ronco C, D'Arrigo G, Barbera V, Russo D, Di Iorio BR, Uguccioni M, Paoletti E, Ravera M, Fusaro M, Bellasi A.

Int J Cardiol. 2019 Mar 1;278:243-249. doi: 10.1016/j.ijcard.2018.11.119. Epub 2018 Nov 29.

PMID:
30538058
21.

Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options.

Di Lullo L, Ronco C, Granata A, Paoletti E, Barbera V, Cozzolino M, Ravera M, Fusaro M, Bellasi A.

Cardiorenal Med. 2019;9(1):8-21. doi: 10.1159/000493395. Epub 2018 Oct 25. Review.

22.

Chronic kidney disease: A model of impaired vascular remodeling.

Bellasi A, Papagni S, Di Lullo L.

Atherosclerosis. 2018 Dec;279:88-90. doi: 10.1016/j.atherosclerosis.2018.10.001. Epub 2018 Oct 10. No abstract available.

PMID:
30342775
23.

Cardiorenal Syndrome: An Overview.

Ronco C, Bellasi A, Di Lullo L.

Adv Chronic Kidney Dis. 2018 Sep;25(5):382-390. doi: 10.1053/j.ackd.2018.08.004. Review.

PMID:
30309455
24.

Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?

Ravera M, Bussalino E, Paoletti E, Bellasi A, Di Lullo L, Fusaro M.

Int J Cardiol. 2019 Jan 1;274:179-185. doi: 10.1016/j.ijcard.2018.07.066. Epub 2018 Sep 1. Review.

PMID:
30177235
25.

Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data.

Di Lullo L, Tripepi G, Ronco C, De Pascalis A, Barbera V, Granata A, Russo D, Di Iorio BR, Paoletti E, Ravera M, Fusaro M, Bellasi A.

J Nephrol. 2018 Oct;31(5):751-756. doi: 10.1007/s40620-018-0501-7. Epub 2018 Jun 7.

PMID:
29882198
26.

Trophic transfer of persistent organic pollutants through a pelagic food web: The case of Lake Como (Northern Italy).

Mazzoni M, Boggio E, Manca M, Piscia R, Quadroni S, Bellasi A, Bettinetti R.

Sci Total Environ. 2018 Nov 1;640-641:98-106. doi: 10.1016/j.scitotenv.2018.05.307. Epub 2018 May 30.

PMID:
29859446
27.

[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].

Bellasi A, Cozzolino M, Malberti F, Cancarini G, Esposito C, Genderini A, Guastoni CM, Ondei P, Pontoriero G, Teatini U, Vezzoli G, Messa P, Locatelli F.

G Ital Nefrol. 2018 May;35(3). pii: 2018-vol3. Italian.

PMID:
29786181
28.

[Update 2017 of the KDIGO guidelines on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). What are the real changes?]

Pasquali M, Bellasi A, Cianciolo G, Massimetti C, Mereu MC, Morrone L, Panuccio V; A nome del GdS Elementi Traccia e Metabolismo Minerale della Società Italiana di Nefrologia.

G Ital Nefrol. 2018 May;35(3). pii: 2018-vol3. Italian.

PMID:
29786179
29.

Cardiovascular calcification: The emerging role of micronutrients.

Bellasi A, Di Lullo L, Raggi P.

Atherosclerosis. 2018 Jun;273:119-121. doi: 10.1016/j.atherosclerosis.2018.04.019. Epub 2018 Apr 20. No abstract available.

PMID:
29705018
30.

Among markers of risk, uric acid remains a two-faced Janus awaiting definitive framing.

Bellasi A, Raggi P.

Atherosclerosis. 2018 May;272:219-221. doi: 10.1016/j.atherosclerosis.2018.03.017. Epub 2018 Mar 10. No abstract available.

PMID:
29551186
31.

CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy.

Bellasi A, Morrone L, Mereu MC, Massimetti C, Pelizzaro E, Cianciolo G, Pasquali M, Panuccio V; working group on CKD-MBD of the Italian Society of Nephrology.

J Nephrol. 2018 Aug;31(4):585-591. doi: 10.1007/s40620-018-0481-7. Epub 2018 Mar 7.

PMID:
29516322
32.

Vascular inflammation: A call for a specific and sensitive biomarker?

Bellasi A, Di Lullo L, Di Iorio B.

Atherosclerosis. 2018 Apr;271:235-236. doi: 10.1016/j.atherosclerosis.2018.02.018. Epub 2018 Feb 12. No abstract available.

PMID:
29463388
33.

Nutritional therapy in autosomal dominant polycystic kidney disease.

Di Iorio BR, Cupisti A, D'Alessandro C, Bellasi A, Barbera V, Di Lullo L.

J Nephrol. 2018 Oct;31(5):635-643. doi: 10.1007/s40620-018-0470-x. Epub 2018 Jan 17. Review.

PMID:
29344814
34.

[Clinical practice for the diagnosis of cardiac arrhythmias in patients on renal replacement therapy: data from a Lombard survey].

Genovesi S, Nava E, Pasa A, Corghi E, Ondei P, Marta E, Bellasi A, Malberti F, Teatini U, Guastoni CM, Spatola L, Luise MC, Tiboldo R, Bertoli S, Messa P, Doria M, Gallieni M, Cozzolino M, Spotti D, Sala V, Sironi E, Boriani G.

G Ital Nefrol. 2017 Dec 5;34(Nov-Dec). pii: 2017-vol6. Italian.

PMID:
29207228
35.

Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease.

Di Iorio BR, Marzocco S, Bellasi A, De Simone E, Dal Piaz F, Rocchetti MT, Cosola C, Di Micco L, Gesualdo L.

Nephrol Dial Transplant. 2018 May 1;33(5):804-813. doi: 10.1093/ndt/gfx203.

PMID:
28992314
36.

[Neprilysin inhibition and chronic kidney disease].

Di Lullo L, Ronco C, Bellasi A, Cozzolino M, Floccari F, Barbera V, Verdesca S, Rivera R, De Pascalis A, Mudoni A, Santoro A.

G Ital Nefrol. 2017 Sep 28;34(5):102-112. Review. Italian.

37.

Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.

Galassi A, Bellasi A, Ciceri P, Pivari F, Conte F, Cozzolino M.

Expert Rev Clin Pharmacol. 2017 Oct;10(10):1073-1084. doi: 10.1080/17512433.2017.1371011. Epub 2017 Sep 4. Review.

PMID:
28846459
38.

[Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].

Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C.

G Ital Nefrol. 2017 Apr;34(2):58-73. Review. Italian.

PMID:
28682563
39.

[NOACs and Chronic kidney disease].

Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C.

G Ital Nefrol. 2017 Mar;34(Suppl 69):188-204. Review. Italian.

PMID:
28682039
40.

[Hepato-renal syndrome].

Di Lullo L, Ronco C, Barbera V, Santoboni F, Bellasi A.

G Ital Nefrol. 2017 Mar;34(Suppl 69):178-187. Review. Italian.

PMID:
28682038
41.

[CKD-MBD, cardiovascular involvement and prognosis].

Bellasi A, Mangano M, Galassi A, Cozzolino M.

G Ital Nefrol. 2017 Mar;34(Suppl 69):150-161. Review. Italian.

PMID:
28682036
42.

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.

Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A.

Ther Clin Risk Manag. 2017 Jun 1;13:679-689. doi: 10.2147/TCRM.S108490. eCollection 2017. Review.

43.

Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.

Di Lullo L, Ronco C, Cozzolino M, Russo D, Russo L, Di Iorio B, De Pascalis A, Barbera V, Galliani M, Vitaliano E, Campana C, Santoboni F, Bellasi A.

Thromb Res. 2017 Jul;155:38-47. doi: 10.1016/j.thromres.2017.04.027. Epub 2017 May 4. Review.

PMID:
28482261
44.

Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.

Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, Cozzolino M, Ronco C.

Indian Heart J. 2017 Mar - Apr;69(2):255-265. doi: 10.1016/j.ihj.2017.01.005. Epub 2017 Jan 22. Review.

45.

Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease.

Bellasi A, Galassi A, Mangano M, Di Lullo L, Cozzolino M.

Curr Drug Metab. 2017;18(7):680-688. doi: 10.2174/1389200218666170427112735. Review.

PMID:
28460623
46.

The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents.

Di Lullo L, Mangano M, Ronco C, Barbera V, De Pascalis A, Bellasi A, Russo D, Di Iorio B, Cozzolino M.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S295-S305. doi: 10.1016/j.dsx.2017.03.005. Epub 2017 Mar 6. Review.

PMID:
28292575
47.

Epidemiology of low-proteinuric chronic kidney disease in renal clinics.

De Nicola L, Provenzano M, Chiodini P, Borrelli S, Russo L, Bellasi A, Santoro D, Conte G, Minutolo R.

PLoS One. 2017 Feb 17;12(2):e0172241. doi: 10.1371/journal.pone.0172241. eCollection 2017.

48.

[Newer anti - diabetic therapies and chronic kidney disease].

Di Lullo L, Ronco C, Barbera V, Cozzolino M, Santoboni F, Villani A, De Pascalis A, Bellasi A.

G Ital Nefrol. 2017 Jan-Feb;34(1). pii: gin/34.1.2. Review. Italian.

PMID:
28177092
49.

Assessment of intradialysis calcium mass balance by a single pool variable-volume calcium kinetic model.

di Filippo S, Carfagna F, la Milia V, Bellasi A, Casagrande G, Bianchi C, Vito D, Costantino ML, Rombolà G, Minoretti C, Schönholzer C, Pontoriero G, Locatelli F.

Hemodial Int. 2018 Jan;22(1):126-135. doi: 10.1111/hdi.12531. Epub 2017 Feb 5.

PMID:
28164430
50.

Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment.

Di Lullo L, Bellasi A, Russo D, Cozzolino M, Ronco C.

Int J Cardiol. 2017 Jan 15;227:143-150. doi: 10.1016/j.ijcard.2016.11.156. Epub 2016 Nov 9. Review.

PMID:
27863290

Supplemental Content

Loading ...
Support Center